LANSOPRAZOLE- lansoprazole capsule, delayed release 
Major Pharmaceuticals

----------

Drug Facts

Active ingredient (in each capsule)

Lansoprazole 15 mg

Purpose

Acid reducer

Use

Warnings

Allergy alert: Do not use if you are allergic to lansoprazole.

Do not use

  • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.

Ask a doctor before use if you have

  • liver disease
  • had heartburn over 3 months. This may be a sign of a more serious condition.
  • heartburn with lightheadedness, sweating or dizziness
  • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
  • frequent chest pain
  • frequent wheezing, particularly with heartburn
  • unexplained weight loss
  • nausea or vomiting
  • stomach pain

Ask a doctor or pharmacist before use if you are

taking

  • warfarin (blood-thinning medicine)
  • prescription antifungal or anti-yeast medicines
  • digoxin (heart medicine)
  • theophylline (asthma medicine)
  • tacrolimus (immune system medicine)
  • atazanavir (medicine for HIV infection)

Stop use and ask a doctor if

  • your heartburn continues or worsens
  • you need to take this product for more than 14 days
  • you need to take more than 1 course of treatment every 4 months
  • you get diarrhea

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

14-Day Course of Treatment

Repeated 14-Day Courses (if needed)

Other information

Inactive ingredients

colloidal silicon dioxide, D&C red No. 33, D&C yellow No. 10, FD&C blue No. 1, FD&C red No. 40, gelatin, hypromellose, magnesium carbonate, methacrylic acid copolymer dispersion, polyethylene glycol, polysorbate 80, sucrose, sugar spheres, talc, titanium dioxide

Questions or comments?

Call 1-800-616-2471

Principal Display Panel

Heartburn Relief 24 Hour™

Lansoprazole Delayed-Release Capsules, 15 mg

Acid Reducer

Capsules

Sodium Free

*Compare to the active ingredient of Prevacid®24HR

*This product is not manufactured or distributed by Takeda Pharmaceuticals North America, Inc., owner of the registered trademark Prevacid®, or by Novartis Consumer Health, Inc., distributor of the Prevacid®24HR product. 

KEEP OUTER CARTON AND PACKAGE INSERT. THEY CONTAIN IMPORTANT INFORMATION.

TAMPER-EVIDENT BOTTLE: DO NOT USE IF INNER FOIL SEAL IMPRINTED WITH "SEALED FOR YOUR PROTECTION" OR DARK BLUE TO BLACK GELATIN BAND AROUND THE CENTER OF EACH CAPSULE IS MISSING OR BROKEN.

Distributed By MAJOR® PHARMACEUTICALS

31778 Enterprise Drive

Livonia, MI 48150 USA

Product of India

Product Label

Lansoprazole 15 mg

Major Heartburn Relief 24 Hour Capsules

LANSOPRAZOLE 
lansoprazole capsule, delayed release
Product Information
Product TypeHUMAN OTC DRUG LABELItem Code (Source)NDC:0904-6282(NDC:55648-140)
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LANSOPRAZOLE (LANSOPRAZOLE) LANSOPRAZOLE15 mg
Inactive Ingredients
Ingredient NameStrength
D&C RED NO. 33 
D&C YELLOW NO. 10 
FD&C BLUE NO. 1 
FD&C RED NO. 40 
GELATIN 
HYPROMELLOSES 
MAGNESIUM CARBONATE 
POLYETHYLENE GLYCOLS 
POLYSORBATE 80 
SILICON DIOXIDE 
STARCH, CORN 
SUCROSE 
TALC 
TITANIUM DIOXIDE 
METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) 
Product Characteristics
ColorPINK (Opaque dark pink cap) , GREEN (Opaque dark green body) Scoreno score
ShapeCAPSULESize16mm
FlavorImprint Code W;140
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:0904-6282-411 in 1 CARTON
114 in 1 BOTTLE
2NDC:0904-6282-712 in 1 CARTON
214 in 1 BOTTLE
3NDC:0904-6282-423 in 1 CARTON
314 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20272703/29/2012
Labeler - Major Pharmaceuticals (191427277)
Registrant - P and L Development of New York Corporation (800014821)

Revised: 4/2013
Document Id: 6ac27ac4-7056-469c-a5ee-046eddc79e54
Set id: eeb3b034-3d11-4872-abe9-4c945f76d86e
Version: 4
Effective Time: 20130416
 
Major Pharmaceuticals